These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Mapping an Adeno-associated Virus 9-Specific Neutralizing Epitope To Develop Next-Generation Gene Delivery Vectors. Giles AR; Govindasamy L; Somanathan S; Wilson JM J Virol; 2018 Oct; 92(20):. PubMed ID: 30089698 [TBL] [Abstract][Full Text] [Related]
11. Examining the cross-reactivity and neutralization mechanisms of a panel of mAbs against adeno-associated virus serotypes 1 and 5. Harbison CE; Weichert WS; Gurda BL; Chiorini JA; Agbandje-McKenna M; Parrish CR J Gen Virol; 2012 Feb; 93(Pt 2):347-355. PubMed ID: 22071509 [TBL] [Abstract][Full Text] [Related]
12. Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8. Gurda BL; Raupp C; Popa-Wagner R; Naumer M; Olson NH; Ng R; McKenna R; Baker TS; Kleinschmidt JA; Agbandje-McKenna M J Virol; 2012 Aug; 86(15):7739-51. PubMed ID: 22593150 [TBL] [Abstract][Full Text] [Related]
13. Structural and Biophysical Analysis of Adeno-Associated Virus Serotype 2 Capsid Assembly Variants. Bennett A; Gargas J; Kansol A; Lewis J; Hsi J; Hull J; Mietzsch M; Tartaglia L; Muzyczka N; Bhattacharya N; Chipman P; Agbandje-McKenna M; McKenna R J Virol; 2023 Jul; 97(7):e0177222. PubMed ID: 37310260 [TBL] [Abstract][Full Text] [Related]
14. AAV6 K531 serves a dual function in selective receptor and antibody ADK6 recognition. Bennett AD; Wong K; Lewis J; Tseng YS; Smith JK; Chipman P; McKenna R; Samulski RJ; Kleinschmidt J; Agbandje-McKenna M Virology; 2018 May; 518():369-376. PubMed ID: 29604478 [TBL] [Abstract][Full Text] [Related]
16. [The preparation of monoclonal antibodies against AAV2 and study on their characterizations]. Tan SP; Yuan ZH; Tian WH; Dong XY; Wu XB Bing Du Xue Bao; 2009 Jul; 25(4):267-73. PubMed ID: 19769159 [TBL] [Abstract][Full Text] [Related]
17. Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization. Lochrie MA; Tatsuno GP; Christie B; McDonnell JW; Zhou S; Surosky R; Pierce GF; Colosi P J Virol; 2006 Jan; 80(2):821-34. PubMed ID: 16378984 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. Wobus CE; Hügle-Dörr B; Girod A; Petersen G; Hallek M; Kleinschmidt JA J Virol; 2000 Oct; 74(19):9281-93. PubMed ID: 10982375 [TBL] [Abstract][Full Text] [Related]
19. The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes. Sonntag F; Köther K; Schmidt K; Weghofer M; Raupp C; Nieto K; Kuck A; Gerlach B; Böttcher B; Müller OJ; Lux K; Hörer M; Kleinschmidt JA J Virol; 2011 Dec; 85(23):12686-97. PubMed ID: 21917944 [TBL] [Abstract][Full Text] [Related]
20. Coevolution of Adeno-associated Virus Capsid Antigenicity and Tropism through a Structure-Guided Approach. Havlik LP; Simon KE; Smith JK; Klinc KA; Tse LV; Oh DK; Fanous MM; Meganck RM; Mietzsch M; Kleinschmidt J; Agbandje-McKenna M; Asokan A J Virol; 2020 Sep; 94(19):. PubMed ID: 32669336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]